Similar articles

• Immunological approaches to the structure of fibrinogen.

  Tanswell P, Gollwitzer R, Stan-Lotter H, Timpl R. Tanswell P, et al. Thromb Haemost. 1979 Jun 30;41(4):702-8. Thromb Haemost. 1979. PMID: 90395 No abstract available.
• Nature of T lymphocyte recognition of macrophage-associated antigens. III. Definition of the antigenic regions of human fibrinopeptide B involved in guinea pig T-cell responses.

  Thomas DW, Schauster JL, Wilner GD. Thomas DW, et al. Cell Immunol. 1981 Mar 1;58(2):238-45. doi: 10.1016/0008-8749(81)90217-3. Cell Immunol. 1981. PMID: 6163556 No abstract available.
• Immunology of fibrinogen: comparison of serologic and cellular immune responses to human fibrinopeptide B (hFPB).

  Wilner GD, Hsieh K, Thomas DW. Wilner GD, et al. Ann N Y Acad Sci. 1981;370:528-35. doi: 10.1111/j.1749-6632.1981.tb29760.x. Ann N Y Acad Sci. 1981. PMID: 6973946 No abstract available.
• Markers of fibrinogen derivatives used in clinical investigation.

  Soria J, Soria C, Mirshahi M, Samama MM. Soria J, et al. Semin Thromb Hemost. 1985 Apr;11(2):129-32. doi: 10.1055/s-2007-1004369. Semin Thromb Hemost. 1985. PMID: 2412296 Review. No abstract available.
• Genetically abnormal fibrinogens--strategies for structure elucidation, including fibrinopeptide analysis.

  Henschen A, Kehl M, Southan C. Henschen A, et al. Curr Probl Clin Biochem. 1984;14:273-320. Curr Probl Clin Biochem. 1984. PMID: 6391842 Review. No abstract available.